Vera Therapeutics, Inc. (28) | Intellectual Property (3)
- Amendment No. 1 to License Agreement between Novartis International Pharmaceutical AG and Amplyx Pharmaceuticals, Inc. dated September 24, 2019 (Filed With SEC on February 7, 2022)
- License Agreement between Novartis International Pharmaceutical AG and Amplyx Pharmaceuticals, Inc. dated August 26, 2019 (Filed With SEC on February 7, 2022)
- License Agreement by and between the Registrant and Ares Trading S.A., dated as of October 29, 2020 (Filed With SEC on April 23, 2021)
